L. Peter Smith

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.